Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Grant or award General Counsel acquired 669 shares (grant or award)
  2. 4 Grant or award Chief Executive Officer acquired 373 shares (grant or award)
  3. 4 Grant or award Director acquired 400,412 shares (grant or award)
  4. 4 Open-market sale Chief Operating Officer sold 44 shares at $16.69 ($734)
  5. 4 Open-market sale Chief Human Resources Officer sold 810 shares at $15.79 ($12,792)
  6. 4 Open-market sale EVP, Pres., Novocure Oncology sold 598 shares at $15.94 ($9,531)
  7. 4 Open-market sale Chief Operating Officer sold 160 shares at $15.88 ($2,540)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award General Counsel acquired 930 shares (grant or award)
  10. 4 Grant or award Chief Operating Officer acquired 1,055 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 1,239 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 1,286 shares (grant or award)
  13. 4 Grant or award EVP, Pres., Novocure Oncology acquired 1,736 shares (grant or award)
  14. 4 Grant or award Chief Human Resources Officer acquired 1,736 shares (grant or award)
  15. 4 Open-market sale Chief Financial Officer sold 688 shares at $20.14 ($13,857)
  16. 4 Exercise or conversion Chief Operating Officer acquired 124,373 shares (option exercise)
  17. 4 Grant or award Director acquired 4,053 shares (grant or award)
  18. 4 Grant or award Director acquired 4,053 shares (grant or award)
  19. 4 Grant or award Director acquired 4,053 shares (grant or award)
  20. 4 Grant or award Director acquired 4,053 shares (grant or award)

Page 6 of 39 · 780 filings